Lensar (LNSR) Current Deferred Revenue (2019 - 2026)
Lensar's (LNSR) quarterly Current Deferred Revenue came in at $3.0 million in Q1 2026, up 51.18% year-on-year from $2.0 million in Q1 2025, and down 1.98% on a QoQ basis from $3.1 million in Q4 2025.
Lensar (LNSR) Current Deferred Revenue (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Current Deferred Revenue data on file, last reported at $3.0 million in Q1 2026.
- On a quarterly basis, Current Deferred Revenue rose 51.18% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a 51.18% increase from a year earlier, with the FY2025 full-year figure at $3.1 million, up 83.3% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $3.0 million, down from $3.1 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for LNSR reached as high as $3.1 million in Q4 2025 and fell as low as $768000.0 in Q4 2022.
- Historically, Current Deferred Revenue has averaged $1.7 million across 5 years, with a median of $1.6 million in 2023.
- Across the five-year window, Current Deferred Revenue dropped 20.82% in 2022 and jumped 149.87% in 2023, its largest moves.
- Year by year, Current Deferred Revenue stood at $768000.0 in 2022, then soared by 149.87% to $1.9 million in 2023, then retreated by 12.61% to $1.7 million in 2024, then jumped by 83.3% to $3.1 million in 2025, then fell by 1.98% to $3.0 million in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $3.0 million in Q1 2026, $3.1 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.01 Mn |
| Dec 31, 2025 | 3.07 Mn |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 1.92 Mn |
| Sep 30, 2023 | 1.62 Mn |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 768,000.00 |
| Sep 30, 2022 | 830,000.00 |
| Jun 30, 2022 | 974,000.00 |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 970,000.00 |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 1.14 Mn |